Lobbying Filing Details

Total Spending

$590,000

Activities

4

Lobbyists

3

Gov't Entities

8

Filing Information
Filing UUID:
bbc69132-9072-4ee4-a231-16c29b8d00b0
Type:
Q2 - 2nd Quarter - Report
Period:
2023 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2023 at 5:41 PM
Income:
$0
Expenses:
$590,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Christine Bloomquist
Registrant
ASTELLAS PHARMA US, INC.

Pharmaceuticals

Northbrook, Illinois
Client
ASTELLAS PHARMA US, INC.
Illinois, United States of America
Lobbying Activities (4)
Activity 1
Copyright/Patent/Trademark

Issues related to Bayh-Dole Act (Pub.L. 96-517).

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (3)
  • JAMES ROLLINS
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Health Issues

Value of Prescription Drugs, Drug pricing, Biopharmaceutical Innovation and Patient Policy Issues (no specific bills). Issues related to Patient Drug User Fee Reauthorization (no specific bills). FDA User Fee Reauthorization Act of 2022.

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (3)
  • JAMES ROLLINS
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Insurance

Issues related to Pharmacy Benefit Manager reform (no specific bills).

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (1)
  • JONATHAN OEHMEN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Medicare/Medicaid

Transparency Policy Issues, Medicare Part D, Coverage Gap, Rebate Reform, Out-of-Pocket Costs, International Reference Pricing, Oncology Screening Awareness, Value-based Payment Arrangements for Gene Therapy, (no specific bills); HR 5376 Build Back Better Act/Inflation Reduction Act of2022 Title I, Subtitle B, Parts 1-3.

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (3)
  • JAMES ROLLINS
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.